Cardiomyopathies: A revolution in molecular medicine and cardiac imaging

Netherlands Heart Journal

Volumn 17, Issue 12, 2009, Pages 456-457

  Ten Cate, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949596182     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/BF03086303     Document Type: Editorial

References (12)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29:270-6.
2. van Rijsingen IAW, Hermans-van Ast JF, Arens YHJM, Schalla SM, de Die-Smulders CEM, van den Wijngaard A, et al. Hyper-trophic cardiomyopathy family with double-heterozygous muta-tions; does disease severity suggest double heterozygosity? Neth Heart J. 2009;17:458-63.
3. Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007;28:2732-7.
4. Vehmeijer JT, Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Smets EMA, et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J. 2009;17:464-9.
5. Michels M, Soliman OI, Phefferkorn J, Hoedemaekers YM, Kofflard MJ, Dooijes D, Majoor-Krakauer D, Ten Cate FJ. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J. 2009. [in press].
6. Tio RA, Slart RHJA, de Boer RA, van der Vleuten PA, de Jong RM, van Wijk LM,et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J. 2009;17:470-4.
7. Soliman OI, Geleijnse ML, Michels M, Dijkmans PA, Nemes A, van Dalen BM, et al. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2008;101:1321-7.
8. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2008;1: 184-91.
9. Olimulder MAGM, van Es J, Galjee MA. The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy. Neth Heart J. 2009;17:481-6.
10. Kohnen RF, Baur LHB. A Dutch case of a takotsubo cardio-myopathy after pacemaker implantation. Neth Heart J. 2009;17: 487-90.
11. Ionescu CN, Marcu CB. Unexpected massive myocardial calcifi-cation. Neth Heart J. 2009;17:491.
12. Xia S, Wu B, Zhang X, Hu X. Left ventricular aneurysm in patients with idiopathic dilated cardiomyopathy: clinical analysis of six cases. Neth Heart J. 2009;17:475-80.